Back
New York Times 10K Form
Buy
66
NYT
New York Times
Last Price:
43.15
Seasonality Move:
3.82%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2023-11-08 | 10Q | NYT/New York Times Quarterly |
2023-08-08 | 10Q | NYT/New York Times Quarterly |
2023-05-10 | 10Q | NYT/New York Times Quarterly |
2022-11-02 | 10Q | NYT/New York Times Quarterly |
2022-08-03 | 10Q | NYT/New York Times Quarterly |
2022-05-04 | 10Q | NYT/New York Times Quarterly |
Receive NYT News And Ratings
See the #1 stock for the next 7 days that we like better than NYT
NYT Financial Statistics
Sales & Book Value
Annual Sales: | $2.43B |
---|---|
Cash Flow: | $130.39M |
Price / Cash Flow: | 21.39 |
Annual Sales: | $10.72 |
Price / Book: | 4.06 |
Profitability
EPS (TTM): | 1.39000 |
---|---|
Net Income (TTM): | $232.39M |
Gross Margin: | $1.18B |
Return on Equity: | 14.17% |
Return on Assets: | 9.12% |
New York Times Earnings Forecast
Key New York Times Financial Ratios
- The Gross Profit Margin over the past 40 years for NYT is 48.52%.
- The Selling, General & Administrative Expenses for NYT have been equal to 23.55% of Gross Profit Margin.
- The Research & Development expenses have been 9.43% of Revenue.
- The Interest Expense is 0.44% of Operating Income.
- The Net Earning history of NYT is 9.58% of Total Revenues.
- Per Share Earnings over the last 40 years have been positive in 22 years.
New York Times Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NYSE |
---|---|
Industry: | Media |
Sector: | Communication Services |
Current Symbol: | NYT |
CUSIP: | 650111 |
Website: | nytco.com |
Debt
Debt-to-Equity Ratio: | 0 |
---|---|
Current Ratio: | 1.28 |
Quick Ratio: | 1.13 |
Price-to-Earnings
Trailing P/E Ratio: | 31.19 |
---|---|
Forward P/E Ratio: | 23.36 |
NYT Technical Analysis vs Fundamental Analysis
Buy
66
New York Times (NYT)
is a Buy
Is New York Times a Buy or a Sell?
-
New York Times stock is rated a Buy
The current New York Times [NYT] share price is $43.66. The Score for NYT is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.